177 related articles for article (PubMed ID: 33479631)
21. Electrospinning of cyclodextrin/linalool-inclusion complex nanofibers: Fast-dissolving nanofibrous web with prolonged release and antibacterial activity.
Aytac Z; Yildiz ZI; Kayaci-Senirmak F; Tekinay T; Uyar T
Food Chem; 2017 Sep; 231():192-201. PubMed ID: 28449997
[TBL] [Abstract][Full Text] [Related]
22. Transdermal iontophoretic delivery of hydrocortisone from cyclodextrin solutions.
Chang SL; Banga AK
J Pharm Pharmacol; 1998 Jun; 50(6):635-40. PubMed ID: 9680073
[TBL] [Abstract][Full Text] [Related]
23. Fast-Disintegrating Nanofibrous Web of Pullulan/Griseofulvin-Cyclodextrin Inclusion Complexes.
Hsiung E; Celebioglu A; Kilic ME; Durgun E; Uyar T
Mol Pharm; 2023 May; 20(5):2624-2633. PubMed ID: 37014780
[TBL] [Abstract][Full Text] [Related]
24. Effects of aging on crystallization, dissolution and absorption characteristics of amorphous tolbutamide-2-hydroxypropyl-beta-cyclodextrin complex.
Kimura K; Hirayama F; Arima H; Uekama K
Chem Pharm Bull (Tokyo); 2000 May; 48(5):646-50. PubMed ID: 10823700
[TBL] [Abstract][Full Text] [Related]
25. Thiram/hydroxypropyl-β-cyclodextrin inclusion complex electrospun nanofibers for a fast dissolving water-based drug delivery system.
Gao S; Liu Y; Jiang J; Li X; Ye F; Fu Y; Zhao L
Colloids Surf B Biointerfaces; 2021 May; 201():111625. PubMed ID: 33621750
[TBL] [Abstract][Full Text] [Related]
26. Fast-dissolving electrospun gelatin nanofibers encapsulating ciprofloxacin/cyclodextrin inclusion complex.
Aytac Z; Ipek S; Erol I; Durgun E; Uyar T
Colloids Surf B Biointerfaces; 2019 Jun; 178():129-136. PubMed ID: 30852264
[TBL] [Abstract][Full Text] [Related]
27. Comparative study on inclusion complexation of maltosyl-beta-cyclodextrin, heptakis(2,6-di-O-methyl)-beta-cyclodextrin and beta-cyclodextrin with fucosterol in aqueous and solid state.
Acartürk F; Imai T; Saito H; Ishikawa M; Otagiri M
J Pharm Pharmacol; 1993 Dec; 45(12):1028-32. PubMed ID: 7908969
[TBL] [Abstract][Full Text] [Related]
28. Improvement of solubility and oral bioavailability of 2-(N-cyanoimino)-5-[(E)-4-styrylbenzylidene]-4-oxothiazolidine (FPFS-410) with antidiabetic and lipid-lowering activities in dogs by 2-hydroxypropyl-beta-cyclodextrin.
Hara T; Hirayama F; Arima H; Yamaguchi Y; Uekama K
Chem Pharm Bull (Tokyo); 2006 Mar; 54(3):344-9. PubMed ID: 16508189
[TBL] [Abstract][Full Text] [Related]
29. Formulation and biological evaluation of glimepiride-cyclodextrin-polymer systems.
Ammar HO; Salama HA; Ghorab M; Mahmoud AA
Int J Pharm; 2006 Feb; 309(1-2):129-38. PubMed ID: 16377107
[TBL] [Abstract][Full Text] [Related]
30. Electrospinning of Cyclodextrin Functional Nanofibers for Drug Delivery Applications.
Topuz F; Uyar T
Pharmaceutics; 2018 Dec; 11(1):. PubMed ID: 30586876
[TBL] [Abstract][Full Text] [Related]
31. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin.
Kim JH; Lee SK; Ki MH; Choi WK; Ahn SK; Shin HJ; Hong CI
Int J Pharm; 2004 Mar; 272(1-2):79-89. PubMed ID: 15019071
[TBL] [Abstract][Full Text] [Related]
32. Controlled release of a water-soluble drug, captopril, by a combination of hydrophilic and hydrophobic cyclodextrin derivatives.
Ikeda Y; Kimura K; Hirayama F; Arima H; Uekama K
J Control Release; 2000 May; 66(2-3):271-80. PubMed ID: 10742586
[TBL] [Abstract][Full Text] [Related]
33. Some pharmaceutical and inclusion properties of 2-hydroxybutyl-β-cyclodextrin derivative.
Ishiguro T; Morishita E; Iohara D; Hirayama F; Wada K; Motoyama K; Arima H; Uekama K
Int J Pharm; 2011 Oct; 419(1-2):161-9. PubMed ID: 21839823
[TBL] [Abstract][Full Text] [Related]
34. Polymer-free nanofibers from vanillin/cyclodextrin inclusion complexes: high thermal stability, enhanced solubility and antioxidant property.
Celebioglu A; Kayaci-Senirmak F; İpek S; Durgun E; Uyar T
Food Funct; 2016 Jul; 7(7):3141-53. PubMed ID: 27353870
[TBL] [Abstract][Full Text] [Related]
35. Ondansetron/Cyclodextrin inclusion complex nanofibrous webs for potential orally fast-disintegrating antiemetic drug delivery.
Hsiung E; Celebioglu A; Emin Kilic M; Durgun E; Uyar T
Int J Pharm; 2022 Jul; 623():121921. PubMed ID: 35714816
[TBL] [Abstract][Full Text] [Related]
36. Potential use of 2-hydroxypropyl-beta-cyclodextrin for preparation of orally disintegrating tablets containing dl-alpha-tocopheryl acetate, an oily drug.
Motoyama K; Nagatomo K; Abd Elazim SO; Hirayama F; Uekama K; Arima H
Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1206-12. PubMed ID: 19881268
[TBL] [Abstract][Full Text] [Related]
37. Solid-state 13C nuclear magnetic resonance spectroscopic study on amorphous solid complexes of tolbutamide with 2-hydroxypropyl-alpha- and -beta-cyclodextrins.
Kimura K; Hirayama F; Arima H; Uekama K
Pharm Res; 1999 Nov; 16(11):1729-34. PubMed ID: 10571279
[TBL] [Abstract][Full Text] [Related]
38. Electrospinning of polymer-free nanofibers from cyclodextrin inclusion complexes.
Celebioglu A; Uyar T
Langmuir; 2011 May; 27(10):6218-26. PubMed ID: 21513339
[TBL] [Abstract][Full Text] [Related]
39. Sulfisoxazole/cyclodextrin inclusion complex incorporated in electrospun hydroxypropyl cellulose nanofibers as drug delivery system.
Aytac Z; Sen HS; Durgun E; Uyar T
Colloids Surf B Biointerfaces; 2015 Apr; 128():331-338. PubMed ID: 25769282
[TBL] [Abstract][Full Text] [Related]
40. Electrospun Polymer-Free Nanofibers Incorporating Hydroxypropyl-β-cyclodextrin/Difenoconazole via Supramolecular Assembly for Antifungal Activity.
Gao S; Jiang J; Li X; Ye F; Fu Y; Zhao L
J Agric Food Chem; 2021 Jun; 69(21):5871-5881. PubMed ID: 34013730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
